Joel Greenblatt’s Filana Therapeutics FLNA Stock Holding History

Joel Greenblatt’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-39,726	Closed	-$3.39M	–	1109
2021 Q2	$3.39M	Buy	+39,726	New	+$2.13M	0.14%	207

Other funds holding FLNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Joel Greenblatt's FLNA Position: Q3 2021 in Review

Joel Greenblatt sold out of Filana Therapeutics (FLNA) in Q3 2021, closing a stake of 39,726 shares — an estimated $3.39M sold.

Joel Greenblatt first reported a position in FLNA in Q2 2021 and held it in 1 quarter. The position peaked at $3.39M in Q2 2021. 180 funds tracked by Wall St. Rank hold FLNA as of Q3 2021.

Joel Greenblatt reported no remaining Filana Therapeutics position as of Q3 2021 after selling out during the quarter.
Joel Greenblatt sold 39,726 Filana Therapeutics shares in Q3 2021, an estimated $3.39M.
Joel Greenblatt first reported a position in Filana Therapeutics in Q2 2021 and held it in 1 quarter.
Joel Greenblatt's Filana Therapeutics position peaked at $3.39M in Q2 2021.
180 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2021.

Based on Gotham Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.